期刊文献+

索拉菲尼对骨肉瘤细胞的抑制作用及分子机制研究 被引量:1

Anti-proliferative effect and mechanisms of sorafenib on osteosarcoma
原文传递
导出
摘要 目的研究索拉菲尼对骨肉瘤细胞增殖和凋亡的作用及其分子机制。方法将人骨肉瘤细胞(HOS细胞)分为对照组及索拉菲尼组,用3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐比色法观察索拉菲尼对HOS细胞活力的影响,用蛋白质印迹法检测凋亡相关蛋白变化,用Real-time PCR检测let-7d变化情况。结果索拉菲尼可抑制HOS细胞活力,并呈剂量和浓度依赖性;同时,索拉菲尼可以抑制Lin28表达,同时促进let-7d表达;过表达Lin28可以逆转索拉菲尼的促凋亡作用。结论索拉菲尼通过调控Lin28/le-7d环路来促进骨肉瘤细胞凋亡。 Objective To investigate the pro- apoptotic effect and mechanism of sorafenib on osteosareoma. Methods HOS cells was divi- ded into control group and sorafenib group. 3 - (4,5 - dimethyl - 2 - thiazolyl) -2,5 - diphenyl - 2 - H - tetrazolium bromide (MTF) assay was chosen to investigate the effect of sorafenib on cell viability. Western blot was applied to detect the expression of proteins, and real - time RT- PCR were used to detect the expression of mRNAs. Results The results of MTr assay showed that sorafenib inhibit the proliferation of HOS cells in an dose - and time -dependent manner. Sorafenib induced the inhibition of lin - 28 and increase of let - 7d. Further study showed that Lin28 could attenuate the pro - apoptotic effect of sorafenibin HOS cells. Conclusion Sorafenib induces apoptosis of HOS cells by disrup- ting Lin28/let- 7d feedback.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2015年第20期2034-2036,共3页 The Chinese Journal of Clinical Pharmacology
基金 浙江省医药卫生科技计划基金资助项目(2014KYB315)
关键词 骨肉瘤 索拉菲尼 细胞凋亡 Lin28同系物A 微小核苷酸let-7d osteosarcoma sorafenib apoptosis lin - 28 homolog A microRNA let - 7d
  • 相关文献

参考文献9

  • 1Han K, Chen X, Bian N, et al. MicroRNA profiling identifies MiR -195 suppresses osteosarcoma cell metastasis by targeting CCND1 [ J]. Oncotarget, 2015, 6:8875 - 8889.
  • 2Liu XW, Zi Y, Xiang LB, et al. Periosteal osteosarcoma : a review of clinical evidence [J]. Int J Clin Exp Med, 2015, 8:37 -44.
  • 3Eisen T, Ahmad T, Flaherty KT, et al. Sorafenib in advanced mela- noma:a Phase II randomised discontinuation trial analysis [ J ]. Br J Cancer, 2006, 95:581 -586.
  • 4Zhang CZ, Wang XD, Wang HW, et al. Sorafenib inhibits liver cancer growth by decreasing mTOR, AKT, and PI3K expression [ J]. J Balkan Union Oncol, 2015, 20:218 - 222.
  • 5Yu W, Tang L, Lin F, et al. High - intensity focused ultrasound: Noninvasive treatment for local unresectable recurrence of osteosarco- ma [J]. Surg Oncol, 2015, 24:9- 15.
  • 6Zhang J, Yah YG, Wang C, et al. MicroRNAs in osteosareoma [ J]. Int J Clin Chem, 2015, 444:9 -17.
  • 7Srivastava SK, Arora S, Averett C, et al. Modulation of microRNAs by phytochemicals in cancer:underlying mechanisms and translational significance [J]. Biomed Res Int, 2015, 2015:848710.
  • 8Liu JM, Long XH, Zhang GM, et al. Let -7g reverses malignant phenotype of osteosarcoma cells by targeting Aurora - B [ J ]. Int J Clin Exp Pathol, 2014, 7:4596 -4606.
  • 9Thornton JE, Gregory RI. How does Lin28 let - 7 control develop- ment and disease? [J]. Trends Cell Biol, 2012, 22:474 -482.

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部